
Join to View Full Profile
2219 Bath St"# William"Santa Barbara, CA 93105
Phone+1 805-682-7640
Fax+1 805-682-3332
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jordan Pinsker, MD is a pediatric endocrinologist in Santa Barbara, California. He is currently licensed to practice medicine in California, Hawaii, and Texas.
Education & Training
- National Capital ConsortiumFellowship, Pediatric Endocrinology, 2004 - 2007
- San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 2001 - 2004
- Albany Medical CollegeClass of 2001
Certifications & Licensure
- CA State Medical License 2003 - 2026
- HI State Medical License 2008 - 2016
- TX State Medical License 2002 - 2009
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
- American Board of Preventive Medicine Clinical Informatics
Publications & Presentations
PubMed
- 1 citationsGlycemic and Patient-Reported Outcomes for Users of a New, Compact Automated Insulin Delivery System: A First Report.Halis K Akturk, Kagan E Karakus, Edwin D'Souza, Kimia Z Assadi, Jordan E Pinsker
Journal of Diabetes Science and Technology. 2025-03-01 - Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers w...Sue A Brown, Lori M Laffel, Halis K Akturk, Gregory P Forlenza, Viral N Shah
Diabetes Technology & Therapeutics. 2025-03-01 - 2 citationsControl-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial.Anders L Carlson, Timothy E Graham, Halis K Akturk, David R Liljenquist, Richard M Bergenstal
Journal of Diabetes Science and Technology. 2024-11-01
Press Mentions
- Tandem Has Positive Data for Automated Insulin Delivery in Type 2 Diabetes PopulationMarch 19th, 2025
- Tandem Diabetes Care Receives FDA Clearance for Control-IQ+ Technology for Type 2 DiabetesFebruary 25th, 2025
- Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 DiabetesFebruary 25th, 2025
- Join now to see all